NIH launches trial of Zika vaccine candidate
A clinical trial to evaluate a candidate vaccine for Zika virus is underway, with preliminary results from the multisite phase I trial expected by the end of 2016.
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health,...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Clinical Trials | Dermatology | Health | Infectious Diseases | National Institutes of Health (NIH) | Skin | Vaccines | Zika Virus